About this trial
APAORL2 study aims to evaluate the efficacy of a physical activity program on the sedentary and physical activity level during the 18-month program.
APAORL2 study is a randomized, open label, controlled, monocentric, intervention study that will be conducted among 96 patients treated for localized upper aerodigestive tract cancer.
Eligibility criteria
Qualifiers
Patients ≥18 years
newly diagnosed, histologically proven Upper Aerodigestive Tract Cancer, non-metastatic,
life expectancy ≥18 months
having a smartphone, tablet or computer with an internet connection enabling remote physical Activity sessions for the experimental group
Disqualifiers
Presenting a contraindication to moderate physical activity
Deprived of their liberty by court or administrative decision
Unable to be followed for medical, social, family, geographic or psychological reasons for the duration of the study,
Trial design
Treatments tested in this trial
- behavioral
- Sedentary
Treatment groups
Sponsors and collaborators
Centre Hospitalier de Valence
Lead sponsor
Claude Bernard University
Collaborator